Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nowak is a precision medicine company that leverages advanced multiplexed tissue imaging and artificial intelligence to transform cancer diagnosis and treatment selection. Spun out of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the company's platform provides high-resolution spatial maps of the tumor microenvironment, enabling a deeper understanding of cellular interactions and drug responses. By quantifying dozens of biomarkers simultaneously in a single tissue section, Nowak aims to provide clinicians with actionable insights to personalize oncology care and improve patient outcomes. The company's technology is designed to support both clinical diagnostics and pharmaceutical drug development programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nowak.